Can a 'flawless' live vector vaccine strain be engineered? (Q45197812)

10 December 2017

Can a 'flawless' live vector vaccine strain be engineered? (English)

1 reference

10 December 2017

0 references

Galen JE

1

1 reference

PubMed ID

11514219

10 December 2017

Levine MM

series ordinal

2

1 reference

10 December 2017

1 August 2001

1 reference

10 December 2017

Trends in Microbiology

1 reference

10 December 2017

9

1 reference

10 December 2017

8

1 reference

10 December 2017

372-376

1 reference

Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Metabolic load and heterologous gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Effects of recombinant plasmid size on cellular processes in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Effects of genes exerting growth inhibition and plasmid stability on plasmid maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Evaluation of the hok/sok killer locus for enhanced plasmid stability

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Plasmid maintenance in Escherichia coli recombinant cultures is dramatically, steadily, and specifically influenced by features of the encoded proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Overexpression of an mRNA dependent on rare codons inhibits protein synthesis and cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Metabolic approaches for the optimisation of recombinant fermentation processes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Heat-shock and stringent responses have overlapping protease activity in Escherichia coli. Implications for heterologous protein yield

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Paradigms of plasmid organization

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Surface-displayed viral antigens on Salmonella carrier vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Display of beta-lactamase on the Escherichia coli surface: outer membrane phenotypes conferred by Lpp'-OmpA'-beta-lactamase fusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Processing by OmpT of fusion proteins carrying the HlyA transport signal during secretion by the Escherichia coli hemolysin transport system.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Positive selection procedure for entrapment of insertion sequence elements in gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902096-0

7 January 2021

10.1016/S0966-842X(01)02096-0

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

11514219